Sustained steroid-free clinical remission in patients with moderate to severe Crohn's disease treated with adalimumab

被引：3
|
作者：
Hanauer, Stephen B.
Kaam, M. A.
Colombel, J. F.
Sandborn, W. J.
Rutgeerts, P.
Kent, J. D.
Pollack, P. F.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] St Marks Hosp, Harrow, Middx, England
[3] CHU Lille, F-59037 Lille, France
[4] Mayo Clin Rochester, Rochester, MN USA
[5] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-01181
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1181
引用
收藏
页码：S460 / S460
页数：1
相关论文
共 50 条
  • [1] Steroid-Free Remission and Fistula Closure in Adalimumab-Treated Patients with Moderate to Severe Crohn's Disease: the Access Trial
    Panaccione, Remo
    Loftus, Edward V.
    Binion, David C.
    McHugh, Kevin
    Chen, Naijun
    Guerette, Benoit
    Chao, Jingdong
    Mulani, Parvez
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A653 - A653
  • [2] Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease
    Kamm, M. A.
    Hanauer, S. B.
    Panaccione, R.
    Colombel, J. -F.
    Sandborn, W. J.
    Pollack, P. F.
    Zhou, Q.
    Robinson, A. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 306 - 317
  • [3] Steroid-free remission in adalimumab-treated pediatric patients with moderately to severely active Crohn's disease in the IMAgINE 1 trial
    Crandall, W.
    Griffiths, A.
    Colletti, R.
    Ruemmele, F.
    Faubion, W. W.
    Hyams, J. S.
    Lazar, A.
    Li, Y.
    Eichner, S.
    Thakkar, R. B.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 150 - 150
  • [4] Steroid-free remission in adalimumab-treated paediatric patients with moderately to severely active Crohn's disease in the IMAgINE 1 trial
    Griffiths, A.
    Crandall, W.
    Colletti, R.
    Ruemmele, F.
    Faubion, W. A.
    Hyams, J.
    Lazar, A.
    Li, Y.
    Eichner, S.
    Thakkar, R. B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S12 - S12
  • [5] Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial
    Griffiths, Anne M.
    Crandall, Wallace
    Colletti, Richard B.
    Ruemmele, Frank
    Faubion, William A.
    Hyams, Jeffrey S.
    Lazar, Andreas
    Li, Yao
    Eichner, Samantha
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S213 - S213
  • [6] Adalimumab Therapy maintains steroid-free remission and Fistula Closure in patients with moderate to severe Crohn's Disease Results of an Open-Label Study in Canada (ACCESS)
    Panaccione, R.
    Loftus, E., Jr.
    Binion, D.
    McHugh, K.
    Chen, N.
    Chao, J.
    Mulani, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S43 - S43
  • [7] Factors influencing the time to and outcome of dose escalation of adalimumab in Crohn's disease patients who achieved steroid-free remission on adalimumab
    Mantzaris, G. J.
    Kyriakos, N.
    Papamichael, K.
    Archavlis, E.
    Tzannetakou, X.
    Internos, I.
    Anastasiadis, S.
    Karatzas, P.
    Tsironikos, D.
    Drougas, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S269 - S270
  • [8] Sustained clinical remission in patients with moderate to severe Crohn's disease with adalimumab, regardless of anti-TNF history or concomitant immunosuppressant therapy
    Hanauer, Stephen B.
    D'Haens, G. R.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S457 - S457
  • [9] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Ghosh, Subrata
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (10): : 540 - 541
  • [10] How effective is adalimumab for inducing remission in patients with moderate-to-severe Crohn's disease?
    Subrata Ghosh
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 540 - 541
12345